A small clinical trial by researchers at Harvard University and elsewhere found that using the asthma drug albuterol in combination with an existing medication for Multiple Sclerosis “improves clinical outcomes in patients.”
The researchers tracked 39 patients randomly placed in two groups for a total of two years. One of the groups got injections of the MS drug glatiramer acetate plus an oral dose of albuterol daily. The other group of patients got just the shots. The patients who got the combined therapy experienced “a delay in the time to first relapse,” according to the study in the current issue of the Archives of Neurology.
“Treatment with glatiramer acetate plus albuterol is well tolerated and improves clinical outcomes in patients with multiple sclerosis,” the researchers concluded.
To check out more Check Up items go to www.philly.com/checkup.